NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

It won’t be even close to $1 on UK approval alone! They will need reimbursement support to get to a $1.5B market cap. Otherwise, the revenues will not exceed $10-15M annually. At those revenues, I
doubt the market will even value NWBO at where it is today given the need for ongoing dilution, how long everything has taken, and lack of clarity around FDA BLA.

The major re-rating (at $1 or thereabouts) would only come with significant non dilutive funding from big pharma. But that ain’t happening.

Any spike we get at UK approval (if there is one!) won’t last long at all. It will be another opportunity for LP’s financiers and shorts to make a ton of money again as bag holders wait for the elusive $1, which will never come! ;)